Valproate-induced thrombocytopenia: a prospective monotherapy study.
about
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.Anticonvulsant drugs and hematological disease.Complications to invasive epilepsy surgery workup with subdural and depth electrodes: a prospective population-based observational study.Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individualsEpilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapyBrivaracetam for the treatment of epilepsy.The long-term safety of antiepileptic drugs.Management of adverse effects of mood stabilizers.Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.Safety profile of intracranial electrode implantation for video-EEG recordings in drug-resistant focal epilepsy.Valproate-induced enuresis: a prospective study.Thrombotic microangiopathy associated with Valproic acid toxicityAnemia secondary to valproic acid therapy in a 13-year-old boy: a case report.Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.Megakaryocyte lineage development is controlled by modulation of protein acetylation.A review of valproate in psychiatric practice
P2860
Q33400189-38B86E56-FC4B-4D79-9885-BFCEB67E8A2FQ33413868-5C67F9A4-9FB1-4B53-A801-E1D72AE03732Q33834532-8A03414A-0BF2-405F-A06A-72C269D70A6EQ35131181-AC769E89-2BC7-4B1C-AB18-E1C4D50286C8Q36893208-671DDCFA-4472-4653-822C-CB2759F0362CQ37891095-B8F473EC-8B03-451A-8D9B-87AC58D69F4EQ38106856-59956EB6-DDD9-4BD5-B0AC-3F049985EA44Q38530476-5A47A352-2515-4830-9816-0F1C6C3995BDQ38761893-85EE46E3-80CC-46F7-A75F-A97885C5CEE6Q40495858-FE40A09E-EBD0-4636-8646-758AAB7EE0B3Q41161282-E8AACF4E-CBA6-4E8C-986F-724DAD91B843Q41247102-FB7CBA56-9744-4E2B-B41E-6B5B812F91E9Q42429049-2A9EE3E2-44F7-4B04-804F-617F5F12FC15Q46501572-89811440-7F10-4A21-8F02-9BD53D61D398Q47278904-FED14796-70B9-4317-85B6-155783D88A0CQ47566841-81E3E5CF-8CF0-4816-B1E7-A9FCCA5FA522Q48114699-00CF3758-941A-4493-979C-3B7D3052BF29Q48469935-287CA10C-0439-41B0-BBE0-850F7AB91655Q48487114-F6299232-55E3-4E06-8D36-90AF166E9FC2Q52716487-4F97D6C8-C3DF-4EA7-A00B-6020DAC009A2Q56093713-378D63D2-1FF1-4FED-985F-005F13C0DF6E
P2860
Valproate-induced thrombocytopenia: a prospective monotherapy study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Valproate-induced thrombocytopenia: a prospective monotherapy study.
@ast
Valproate-induced thrombocytopenia: a prospective monotherapy study.
@en
type
label
Valproate-induced thrombocytopenia: a prospective monotherapy study.
@ast
Valproate-induced thrombocytopenia: a prospective monotherapy study.
@en
prefLabel
Valproate-induced thrombocytopenia: a prospective monotherapy study.
@ast
Valproate-induced thrombocytopenia: a prospective monotherapy study.
@en
P2860
P1433
P1476
Valproate-induced thrombocytopenia: a prospective monotherapy study
@en
P2093
Ahmad Beydoun
P2860
P304
P356
10.1111/J.1528-1167.2007.01429.X
P50
P577
2007-11-21T00:00:00Z